Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Antimicrobial Resistance Diagnostics Market, by Technology
1.4.2 LAMEA Antimicrobial Resistance Diagnostics Market, by End User
1.4.3 LAMEA Antimicrobial Resistance Diagnostics Market, by Pathogen
1.4.4 LAMEA Antimicrobial Resistance Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. LAMEA Antimicrobial Resistance Diagnostics Market by Technology
4.1 LAMEA PCR Market by Country
4.2 LAMEA Immunoassay Market by Country
4.3 LAMEA NGS Market by Country
4.4 LAMEA Microbiology Culture Market by Country
4.5 LAMEA Mass Spectrometry Market by Country
4.6 LAMEA Rapid & Point of Care Market by Country
4.7 LAMEA Others Market by Country
Chapter 5. LAMEA Antimicrobial Resistance Diagnostics Market by End-user
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Diagnostic Laboratories Market by Country
5.3 LAMEA Pharmaceutical, Biotechnology Companies & Others Market by Country
Chapter 6. LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen
6.1 LAMEA Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country
6.2 LAMEA Clostridium Difficile (CD) Market by Country
6.3 LAMEA Drug Resistant Campylobacter (DRC) Market by Country
6.4 LAMEA Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country
6.5 LAMEA Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country
6.6 LAMEA Drug Resistant Salmonella (DRNTS) Market by Country
6.7 LAMEA Others Market by Country
Chapter 7. LAMEA Antimicrobial Resistance Diagnostics Market by Country
7.1 Brazil Antimicrobial Resistance Diagnostics Market
7.1.1 Brazil Antimicrobial Resistance Diagnostics Market by Technology
7.1.2 Brazil Antimicrobial Resistance Diagnostics Market by End-user
7.1.3 Brazil Antimicrobial Resistance Diagnostics Market by Pathogen
7.2 Argentina Antimicrobial Resistance Diagnostics Market
7.2.1 Argentina Antimicrobial Resistance Diagnostics Market by Technology
7.2.2 Argentina Antimicrobial Resistance Diagnostics Market by End-user
7.2.3 Argentina Antimicrobial Resistance Diagnostics Market by Pathogen
7.3 UAE Antimicrobial Resistance Diagnostics Market
7.3.1 UAE Antimicrobial Resistance Diagnostics Market by Technology
7.3.2 UAE Antimicrobial Resistance Diagnostics Market by End-user
7.3.3 UAE Antimicrobial Resistance Diagnostics Market by Pathogen
7.4 Saudi Arabia Antimicrobial Resistance Diagnostics Market
7.4.1 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Technology
7.4.2 Saudi Arabia Antimicrobial Resistance Diagnostics Market by End-user
7.4.3 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Pathogen
7.5 South Africa Antimicrobial Resistance Diagnostics Market
7.5.1 South Africa Antimicrobial Resistance Diagnostics Market by Technology
7.5.2 South Africa Antimicrobial Resistance Diagnostics Market by End-user
7.5.3 South Africa Antimicrobial Resistance Diagnostics Market by Pathogen
7.6 Nigeria Antimicrobial Resistance Diagnostics Market
7.6.1 Nigeria Antimicrobial Resistance Diagnostics Market by Technology
7.6.2 Nigeria Antimicrobial Resistance Diagnostics Market by End-user
7.6.3 Nigeria Antimicrobial Resistance Diagnostics Market by Pathogen
7.7 Rest of LAMEA Antimicrobial Resistance Diagnostics Market
7.7.1 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Technology
7.7.2 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by End-user
7.7.3 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen
Chapter 8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Becton, Dickinson and Company
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 BioMérieux S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition, Joint Ventures and Mergers:
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Danaher Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.6 Hologic, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Financial Analysis
8.6.4 Segmental and Regional Analysis
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Acquisition and Mergers:
8.7 Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Molsid SAS
8.8.1 Company Overview
8.9 Visby Medical, Inc.
8.9.1 Company Overview
8.10. Accelerated Technology Laboratories, Inc.
8.10.1 Company Overview
Unique Offerings 
